Szemészet, 2012 (149. évfolyam, 1-4. szám)
2012-07-01 / 2. szám
Effect of blue light therapy Irodalom 1. Csorna Z, Heinz R Orvos H, et al. Neonatal blue light phototherapy could increase the risk of dysplastic nevus development. Pediatrics 2007; 119 (5): 1036-37. 2. Damato B, Elenteri A, Fisher A, et a I. Artificial neural networks estimating survival probability after treatment of choroidal melanoma. Ophthalmology 2008; 115 (9): 1598-1607. 3. Di Cesare S, Maloney S, Fernandes BF et al. The effect of blue light exposure in an ocular melanoma animal model. J Exp Clin Cancer Res 2009; 28 (1): 48. 4. Dobson V, Cowett RM, Riggs LA. Long-term effect of phototherapy on visual function. J Pediatr 1975; 86: 555-559. 5. Gallagher RR Elwood JM, Rootman J, et al. Risk factors for ocular melanoma: Western Canada Melanoma Study. J Natl Cancer Inst 1985; 74: 775-778. 6. Hammer H, Tóth-Molnár E, Oláh J, et al. Cutaneous dysplastic naevi: risk factor for uveal melanoma. Lancet 1995; 346: 255-256. 7. Maisels MJ, McDonagh AF Phototherapy for neomatal jaundice. N Engl J Med 2008; 358 (91:920-928. 8. Manning WS, Greenlee PG, Norton JN. Ocular melanoma in a Long Evans rat. Contemp Top Lab Anim Sei 2004; 43 (11: 44-46. 9. Moseley MJ, Fielder AR. Phototherapy: an ocular hazard revisited. Arch Dis Child 1988; 63: 886-887. 10. Ostrowski G, Pye SD, Laing IA. Do phototherapy hoods really protect the neonate?Acta Paediatr 2000; 89: 874-877. 11. Pane AR, Hirst LW. Ultraviolet light exposure as a risk factor for ocular melanoma in Queensland, Australia. Ophthalmic Epidemiol 2000; 7: 159-167. 12. Robinson J, Moseley MJ, Thompson JR. Eyelid opening in preterm neonates. Arch Dis Child 1989; 64: 943-948. 13. Reynolds JD, Hardy JR, Kennedy KA, et al. Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light reduction in Retinopathy of Prematurity Cooperative Group. N Engl J Med 1998; 338: 1572-1576. 14. Schmidt-Pokrzywniak A, Jockei KH, Bornfeld N, et al. Positive interaction between light iris color and ultraviolet radiation in relation to the risk of uveal melanoma. Ophthalmology 2009; 116: 340-348. 15. Seiberth V, Linderkamp 0, Knorz MC, et al. A controlled trial of light and retinopathy of prematurity. Am J Ophthalmol 1994; 118: 492-495. 16. Shah CR Weis E, Lajous M, et al. Intermittent and chronic ultraviolet light exposue and uveal melanoma. Ophthalmology 2005; 112: 1599-1607. 17. Singh AD, Rennie IG, Seregard S, et al. Sunlight exposure and pathogenesis of uveal melanoma. Surv Ophthalmol 2004; 49: 419-428. 18. Tóth-Molnár E, Hammer H, Oláh J. Cutaneous dysplastic nevi in uveal melanoma 17. patients: markers for prognosis? Melanoma Research 2000; 10: 36-40. 19. Tóth-Molnár E, Oláh, J, Dobozy A, et al. Ocular pigmented findings in patients with dysplastic nevus syndrome. Melanoma Research 2004; 14: 43-47. 20. Vajdic CM, Kricker A, Giblin M, et al. Sun exposure predicts risk of ocular melanoma in Australia. Int J Cancer 2002; 101: 175-182. Levelezési cím Dn Tóth-Molnár Edit, 6727 Szeged, Benczúr Gyula utca 39. E-mail: tme@rytmion.com
